thalidomide has been researched along with Disbacteriosis in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Excerpt | Relevance | Reference |
---|---|---|
"Thalidomide is an important immunomodulatory and antitumor drug and its effects on the gut microbiota still remain unclear." | 1.72 | A metagenome-wide association study of the gut microbiota in recurrent aphthous ulcer and regulation by thalidomide. ( Duan, N; Hu, Q; Huang, F; Huang, J; Jiang, H; Lin, L; Liu, Q; Qian, Y; Ruan, H; Song, Y; Wang, W; Wang, X; Xiong, K; Yan, F; Ye, P; Zhao, M; Zheng, L; Zhu, Y, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Wang, X | 1 |
Xiong, K | 1 |
Huang, F | 1 |
Huang, J | 1 |
Liu, Q | 1 |
Duan, N | 1 |
Ruan, H | 1 |
Jiang, H | 1 |
Zhu, Y | 1 |
Lin, L | 1 |
Song, Y | 1 |
Zhao, M | 1 |
Zheng, L | 1 |
Ye, P | 1 |
Qian, Y | 1 |
Hu, Q | 1 |
Yan, F | 1 |
Wang, W | 1 |
1 other study available for thalidomide and Disbacteriosis
Article | Year |
---|---|
A metagenome-wide association study of the gut microbiota in recurrent aphthous ulcer and regulation by thalidomide.
Topics: Dysbiosis; Gastrointestinal Microbiome; Humans; Metagenome; Stomatitis, Aphthous; Thalidomide | 2022 |